Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer
Domenica Lorusso, Felix Hilpert, Antonio González Martin, Joern Rau, Petronella Ottevanger, Elfriede Greimel, Hans-Joachim Lück, Frédéric Selle, Nicoletta Colombo, Judith R Kroep, Mansoor R Mirza, Regina Berger, Beatriz Pardo, Eva-Maria Grischke, Dominique Berton-Rigaud, Jeronimo Martinez-Garcia, Ignace Vergote, Andrés Redondo, Andrés Cardona, Lydie Bastière-Truchot, Andreas du Bois, Christian Kurzeder
International Journal of Gynecologic Cancer Sep 2019, 29 (7) 1141-1147; DOI: 10.1136/ijgc-2019-000370